m-a-istock-505620793-1
istocksdaily / iStockphoto.com
3 March 2017Americas

Otsuka to acquire Neurovance in $100m deal

Otsuka Pharmaceutical has agreed to acquire Neurovance, a privately held clinical stage pharma company.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Generics
15 March 2022   Otsuka Pharmaceuticals has filed a patent infringement suit against MSN Laboratories targeting the company’s planned generic Samsca heart medication.

More on this story

Generics
15 March 2022   Otsuka Pharmaceuticals has filed a patent infringement suit against MSN Laboratories targeting the company’s planned generic Samsca heart medication.

More on this story

Generics
15 March 2022   Otsuka Pharmaceuticals has filed a patent infringement suit against MSN Laboratories targeting the company’s planned generic Samsca heart medication.